Corbus Pharmaceuticals (CRBP) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street ...

This was the stock's second consecutive day of losses.

This was the stock's fourth consecutive day of losses.

Corbus Pharmaceuticals (CRBP) has been on a downward spiral lately with significant selling pressure. After declining 22.9% over the past four weeks, the stock looks well positioned for a trend ...

Earnings Report 0.090 USD Q4 2022 Earnings Release 11/08/2022 Earnings Report 0.770 USD Q3 2022 Earnings Release 08/10/2022 Disney stock has been publicly traded since 1957 when it had its initial ...

1 Day F 1.95% DJIA 1.11% S&P 500 1.50% Automotive 3.75% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of ...

After hours: March 21 at 7:22:49 PM EDT Loading Chart for CRBP ...